- Home
- IFRX vs RMTI Comparison
IFRX vs RMTI Comparison
Compare IFRX & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- RMTI
- Stock Information
- Founded
- IFRX 2007
- RMTI 1994
- Country
- IFRX Germany
- RMTI United States
- Employees
- IFRX N/A
- RMTI N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- IFRX Health Care
- RMTI Health Care
- Exchange
- IFRX Nasdaq
- RMTI Nasdaq
- Market Cap
- IFRX 53.5M
- RMTI 58.9M
- IPO Year
- IFRX 2017
- RMTI 1998
- Fundamental
- Price
- IFRX $1.14
- RMTI $1.68
- Analyst Decision
- IFRX Strong Buy
- RMTI Strong Buy
- Analyst Count
- IFRX 5
- RMTI 2
- Target Price
- IFRX $7.40
- RMTI $4.00
- AVG Volume (30 Days)
- IFRX 1.0M
- RMTI 3.1M
- Earning Date
- IFRX 11-07-2025
- RMTI 11-11-2025
- Dividend Yield
- IFRX N/A
- RMTI N/A
- EPS Growth
- IFRX N/A
- RMTI N/A
- EPS
- IFRX N/A
- RMTI N/A
- Revenue
- IFRX $191,224.00
- RMTI $87,966,000.00
- Revenue This Year
- IFRX N/A
- RMTI N/A
- Revenue Next Year
- IFRX $1,216.24
- RMTI $10.99
- P/E Ratio
- IFRX N/A
- RMTI N/A
- Revenue Growth
- IFRX 54.36
- RMTI N/A
- 52 Week Low
- IFRX $0.71
- RMTI $0.78
- 52 Week High
- IFRX $2.82
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- IFRX 45.40
- RMTI 60.96
- Support Level
- IFRX $1.45
- RMTI $1.59
- Resistance Level
- IFRX $1.77
- RMTI $1.85
- Average True Range (ATR)
- IFRX 0.21
- RMTI 0.20
- MACD
- IFRX -0.04
- RMTI -0.01
- Stochastic Oscillator
- IFRX 24.94
- RMTI 45.45
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.